High-dose intravitreal chemotherapy in the treatment of high-risk retinoblastoma
Background: Intravitreal chemotherapy (IVitC; intravitreal cytostatic injections) is the most promising field of multiagent chemotherapy for retinoblastoma, and, when combined with systemic multiagent chemotherapy, enables maximum effects on the tumor. Purpose: To improve the method of primary combi...
Saved in:
Main Authors: | N. F. Bobrova (Author), T. A. Sorochynska (Author), S. A. Tronina (Author), T. V. Romanova (Author), O. Yu. Bratishko (Author) |
---|---|
Format: | Book |
Published: |
Ukrainian Society of Ophthalmologists,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improving the ablastic capacity of intravitreal chemotherapy for retinoblastoma
by: N. F. Bobrova, et al.
Published: (2022) -
Features of regression of different stages of retinoblastoma after primary combined (intravitreal plus systemic) polychemotherapy and additional consolidation therapy
by: Nadiya Bobrova, et al.
Published: (2023) -
Ultrastructural changes in the rabbit retina after various one-time doses of intravitreal melphalan
by: N.F. Bobrova, et al.
Published: (2020) -
Clinical and pathomorphological changes in the rabbit retina after an injection of various doses of the cytostatic melphalan
by: N. F. Bobrova, et al.
Published: (2023) -
Vitrectomy in an eye with unsuspected retinoblastoma
by: N.F. Bobrova, et al.
Published: (2018)